Mr Gilman Edwin Wong, the former Chief Executive Officer and director of Sirtex Medical Limited, has pleaded guilty to one charge of insider trading.
Appearing at the Downing Centre Local Court yesterday, Mr Wong pleaded guilty to one charge of insider trading. He was committed to the Sydney District Court for sentencing on a date to be fixed.
The insider trading prosecution relates to Mr Wong’s sale of Sirtex shares on 26 October 2016 while in possession of inside information.
Mr Wong, of Sydney, was the former CEO of Sirtex in the period 2005 to 2017. On 26 October 2016 while in possession of inside information concerning Sirtex’s sales, Mr Wong sold 74,698 Sirtex shares.
He was charged with one count of insider trading under the Corporations Act on 25 September 2018 (18-288MR).
The matter is being prosecuted by the Commonwealth Director of Public Prosecutions.
Published by Australian Securities & Investments Commission. Reproduced with permission.